Literature DB >> 7459580

T3 bladder cancer--the case for salvage cystectomy.

J P Blandy, H R England, S J Evans, H F Hope-Stone, G M Mair, B S Mantell, R T Oliver, A M Paris, R A Risdon.   

Abstract

Seven hundred and four patients with bladder cancer treated by radiotherapy at the London Hospital between 1965 and 1974 have been followed for a minimum period of 5 years. Invasive tumours were usually treated by radical radiotherapy. Cystectomy was reserved for patients whose tumours did not respond to radiation, recurred later on, or who developed complications from radiotherapy. The crude 5-year survival rate for T3 tumours in this series was 38%--similar to that obtained in other centres using pre-operative radiation followed by cystectomy, but this overall figure conceals the important difference between 2 distinct tumour populations. Nearly half of these tumours appear to be radiosensitive, giving a 56% crude 5-year survival rate for T3 tumours. The remainder are radioinsensitive, with only a 17% crude 5-year survival rate for T3 tumours. When there is a good initial response to radiotherapy there would seem to be no necessity to insist upon cystectomy.

Entities:  

Mesh:

Year:  1980        PMID: 7459580     DOI: 10.1111/j.1464-410x.1980.tb03101.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  11 in total

1.  Bricker versus Wallace anastomosis: A meta-analysis of ureteroenteric stricture rates after ileal conduit urinary diversion.

Authors:  Niall F Davis; John P Burke; Ted McDermott; Robert Flynn; Rustom P Manecksha; John A Thornhill
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

2.  Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder.

Authors:  J E Martin; B J Jenkins; R J Zuk; J P Blandy; S I Baithun
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

3.  Morbidity and mortality of radical cystectomy (1971-78 and 1978-85).

Authors:  W F Hendry
Journal:  J R Soc Med       Date:  1986-07       Impact factor: 5.344

Review 4.  New approaches in the use of radiation therapy in the treatment of infiltrative transitional-cell cancer of the bladder.

Authors:  P Warde; M K Gospodarowicz
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 5.  Chemotherapy for bladder cancer in the elderly.

Authors:  D Raghavan
Journal:  Drugs Aging       Date:  1993 Jan-Feb       Impact factor: 3.923

6.  Post-irradiation bladder dysfunction: development of a rat model.

Authors:  J A Vale; W G Bowsher; K Liu; A Tomlinson; H N Whitfield; K R Trott
Journal:  Urol Res       Date:  1993

7.  Preliminary results of concurrent methotrexate, cisplatin and radiation treatment for locally advanced urothelial cancers.

Authors:  M Igawa; S Urakami; H Shirakawa; H Shiina; H Kishi; Y Himeno; T Ishibe; H Kadena; T Usui
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

8.  The role of preoperative intra-arterial doxorubicin chemotherapy in combination with low-dose irradiation for bladder cancer.

Authors:  T Uyama; S Moriwaki; A Yokozeki; K Kitada; I Higa; T Shiotsu; J Fujita
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

9.  Human chorionic gonadotrophin expression and histological findings as predictors of response to radiotherapy in carcinoma of the bladder.

Authors:  J E Martin; B J Jenkins; R J Zuk; R T Oliver; S I Baithun
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

10.  Prognostic factors in a T3 bladder cancer trial. Co-operative Urological Cancer Group.

Authors:  A Babiker; R J Shearer; C E Chilvers
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.